These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34019660)

  • 41. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia.
    Chokshi N; Blumenschein SD; Ahmad Z; Garg A
    J Clin Lipidol; 2014; 8(3):287-95. PubMed ID: 24793350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Volanesorsen for treatment of patients with familial chylomicronemia syndrome.
    Warden BA; Duell PB
    Drugs Today (Barc); 2018 Dec; 54(12):721-735. PubMed ID: 30596391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of chylomicronemia.
    Navarro Hermoso A; Valdivielso P
    Clin Investig Arterioscler; 2021 May; 33 Suppl 2():75-79. PubMed ID: 34006359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1.
    Ahmad Z; Wilson DP
    J Clin Lipidol; 2014; 8(6):635-639. PubMed ID: 25499947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia.
    Serveaux Dancer M; Di Filippo M; Marmontel O; Valéro R; Piombo Rivarola MDC; Peretti N; Caussy C; Krempf M; Vergès B; Mahl M; Marçais C; Moulin P; Charrière S
    J Clin Lipidol; 2018; 12(5):1244-1252. PubMed ID: 30037590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations.
    Vigna GB; Citroni N; Tarugi P; Fellin R
    J Clin Lipidol; 2022; 16(5):591-595. PubMed ID: 35945124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia.
    D'Erasmo L; Gallo A; Di Costanzo A; Bruckert E; Arca M
    Expert Opin Pharmacother; 2020 Oct; 21(14):1675-1684. PubMed ID: 32646313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe hypertriglyceridemia is primarily polygenic.
    Dron JS; Wang J; Cao H; McIntyre AD; Iacocca MA; Menard JR; Movsesyan I; Malloy MJ; Pullinger CR; Kane JP; Hegele RA
    J Clin Lipidol; 2019; 13(1):80-88. PubMed ID: 30466821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment.
    Gallo A; Béliard S; D'Erasmo L; Bruckert E
    Curr Atheroscler Rep; 2020 Aug; 22(11):63. PubMed ID: 32852651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
    Surendran RP; Visser ME; Heemelaar S; Wang J; Peter J; Defesche JC; Kuivenhoven JA; Hosseini M; Péterfy M; Kastelein JJ; Johansen CT; Hegele RA; Stroes ES; Dallinga-Thie GM
    J Intern Med; 2012 Aug; 272(2):185-96. PubMed ID: 22239554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rare genetic variants with large effect on triglycerides in subjects with a clinical diagnosis of familial vs nonfamilial hypertriglyceridemia.
    De Castro-Orós I; Civeira F; Pueyo MJ; Mateo-Gallego R; Bolado-Carrancio A; Lamíquiz-Moneo I; Álvarez-Sala L; Fabiani F; Cofán M; Cenarro A; Rodríguez-Rey JC; Ros E; Pocoví M
    J Clin Lipidol; 2016; 10(4):790-797. PubMed ID: 27578109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic variants in the LPL and GPIHBP1 genes, in patients with severe hypertriglyceridaemia, detected with high resolution melting analysis.
    Ariza MJ; Pérez-López C; Almagro F; Sánchez-Tévar AM; Muñiz-Grijalvo O; Álvarez-Sala Walter LA; Rioja J; Sánchez-Chaparro MÁ; Valdivielso P
    Clin Chim Acta; 2020 Jan; 500():163-171. PubMed ID: 31669931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis.
    Chyzhyk V; Brown AS
    Trends Cardiovasc Med; 2020 Feb; 30(2):80-85. PubMed ID: 31003756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic Variants Associated with Severe Hypertriglyceridemia: LPL, APOC2, APOA5, GPIHBP1, LMF1, and APOE.
    Abedi AH; Yıldırım Şimşir I; Bayram F; Onay H; Özgür S; Mcintyre AD; Toth PP; Hegele RA
    Turk Kardiyol Dern Ars; 2023 Jan; 51(1):10-21. PubMed ID: 36689289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial.
    Rosenson RS; Gaudet D; Ballantyne CM; Baum SJ; Bergeron J; Kershaw EE; Moriarty PM; Rubba P; Whitcomb DC; Banerjee P; Gewitz A; Gonzaga-Jauregui C; McGinniss J; Ponda MP; Pordy R; Zhao J; Rader DJ
    Nat Med; 2023 Mar; 29(3):729-737. PubMed ID: 36879129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting APOC3 in the familial chylomicronemia syndrome.
    Gaudet D; Brisson D; Tremblay K; Alexander VJ; Singleton W; Hughes SG; Geary RS; Baker BF; Graham MJ; Crooke RM; Witztum JL
    N Engl J Med; 2014 Dec; 371(23):2200-6. PubMed ID: 25470695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis.
    Hernandez P; Passi N; Modarressi T; Kulkarni V; Soni M; Burke F; Bajaj A; Soffer D
    Curr Atheroscler Rep; 2021 Sep; 23(11):72. PubMed ID: 34515873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variants of Lipid-Related Genes in Adult Japanese Patients with Severe Hypertriglyceridemia.
    Matsunaga A; Nagashima M; Yamagishi H; Saku K
    J Atheroscler Thromb; 2020 Dec; 27(12):1264-1277. PubMed ID: 32115487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene.
    Rabacchi C; D'Addato S; Palmisano S; Lucchi T; Bertolini S; Calandra S; Tarugi P
    J Clin Lipidol; 2016; 10(4):915-921.e4. PubMed ID: 27578123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness and safety of lomitapide in a patient with familial chylomicronemia syndrome.
    Cefalù AB; Giammanco A; Noto D; Spina R; Cabibi D; Barbagallo CM; Averna M
    Endocrine; 2021 Feb; 71(2):344-350. PubMed ID: 33006726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.